Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ADVANCED PLANT PHARMACEUTICALS ANNOUNCES CONTRACT WITH F & G PHARMACEUTICALS.


West Orange, NJ--(BUSINESS WIRE)--March 22, 1995--Advanced Plant Pharmaceuticals, Inc. (OTC Bulletin Board OTC Bulletin Board

An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system.
: APPI APPI American Psychiatric Publishing, Inc.
APPI American Psychiatric Publishing Inc.
APPI American Psychiatric Press, Inc.
APPI Atmospheric Pressure Photoionization
APPI Advanced Peer-to-Peer Internetworking
APPI Advanced Plant Pharmaceuticals Inc.
), today announced that it has signed an exclusive United Kingdom distribution rights agreement with F & G Pharmaceuticals ("F & G"), a London-based pharmaceutical distributor, for APPI's nutritional product Lochol.

Under the terms of the agreement, F & G must make minimum purchases of Lochol during the period beginning June 1995 and ending December 31, 1996 to maintain its exclusive distribution agreement. This agreement becomes effective upon the payment by F & G of $100,000 to APPI. The full payment has not yet been received. APPI expects this contract will generate revenues for the Company in 1995. Lochol, also known as Metachol, is a plant-based, all-natural nutritional product used as a cholesterol-reducing aid. In clinical studies conducted in Australia and a smaller, double-blind study double-blind study,
n experimental technique in clinical research in which neither the researcher nor the patient knows whether the treatment administered is considered inactive (placebo) or active (medicinal).
 conducted in the United States, Lochol, when combined with dietary modification, demonstrated the ability to lower serum cholesterol and triglycerides Triglycerides
Fatty compounds synthesized from carbohydrates during the process of digestion and stored in the body's adipose (fat) tissues. High levels of triglycerides in the blood are associated with insulin resistance.
, as well as increase high density lipoprotein High density lipoprotein (HDL)
A fraction of total serum lipids, the so called "good" cholesterol.

Mentioned in: Hypercholesterolemia
 levels. Lochol has been available in Australia since February 1993 as an over-the-counter therapeutic nutritional product.

C.J. Lieberman, President and Chief Executive Officer of APPI, commented, "We are very pleased to announce this latest agreement for one of our all-natural, plant-based products."

Pursuant to the Company's recent announcement of declaring one class A warrant and one class B warrant for every four shares of the Company's common stock, management also noted that the delivery date of the warrants of on or about May 23, 1995 is subject to SEC registration.

Advanced Plant Pharmaceuticals, Inc. is a phyto-pharmaceutical (plant derived products) company, whose mission is to research, develop, produce, and distribute botanically based therapeutics. APPI received the first Investigational New Drug Application (IND) from the Food and Drug Administration for an herbal product.

CONTACT: Advanced Plant Pharmaceuticals

C.J. Lieberman, President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  

(914) 362-4129

or

APPI's Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 Counsel:

The Equity Group Inc.

Devin Sullivan (212) 836-9608

Robert Goldstein (212) 371-8660
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 22, 1995
Words:324
Previous Article:IBM TO HELP USERS BREAK SERIAL PORT BOTTLENECKS.
Next Article:Engineers will soon use 'virtual reality' to design computer chips.
Topics:



Related Articles
Jacobs' Scotland office awarded contract from SmithKline Beecham Pharmaceuticals.
Advanced Plant Pharmaceuticals enters Phase II human clinical trials for AIDS and names new president.
Advanced Plant Pharmaceuticals announces the appointment of a financial public relations firm.
Catalytica Pharmaceuticals Announces Manufacturing Agreement With Amgen.
Advanced Plant Pharmaceuticals Announces Signed Letter of Intent for Distribution in Spain.
Glaxo Wellcome Expands Supply Agreement With Catalytica Pharmaceuticals.
UNIGEN/UNIV. OF PANAMA SIGN PLANT COLLECTION PACT.
Underground growing operation is aboveboard.
SEMBIOSYS SIGNS PACT FOR CANGENE PLANT-PRODUCED INSULIN.
Astellas Transfers Three European Plants to Temmler Group, German Pharmaceutical Company.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles